Tektite Genome is an AI-driven genomics Biotech company that develops and represents non-toxic products and services.
Tektite Genome has raised $750K in total funding. The most recent round was Secondary Market. The last funding was announced in September 2026.
Tektite Genome's investors include Steven Crow.
Tektite Genome is headquartered in Long Beach, United States.
Tektite Genome is an AI-driven genomics Biotech company that develops and represents non-toxic products and services.
Tektite Genome is at the Secondary Market stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Tektite Genome — Funding & Investors." VCBacked, September 5, 2026, https://www.vcbacked.co/company/tektite-genome. Accessed November 19, 2026.
VCBacked. (2026). Tektite Genome — Funding & Investors. Retrieved November 19, 2026, from https://www.vcbacked.co/company/tektite-genome
{{cite web |title=Tektite Genome — Funding & Investors |url=https://www.vcbacked.co/company/tektite-genome |website=VCBacked |access-date=November 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Tektite Genome? Request a listing update